Incretin-Based Drugs Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2027
The global incretin-based drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The incretins are gastrointestinal polypeptide hormones. They act to modulate insulin secretion from pancreatic beta cells. The major factor driving the growth of the market is the increasing prevalence of diabetes across the globe.
According to the International
Diabetes Federation (IDF), in 2021, approximately 537 million adults aged 20-79
years has diabetes globally with 3 in 4 adults with diabetes living in low- and
middle-income countries with a mortality rate of 6.7 million people globally.
Additionally, the total number of people living with diabetes is anticipated to
rise to 643 million by 2030 and 783 million by 2045. Moreover, almost 1 in 2
(240 million) adults living with diabetes are undiagnosed. Hence, the
increasing prevalence of diabetes is driving the demand for incretin-based
drugs for the treatment which in turn is driving the growth of the market.
To Request a Sample of our Report on Incretin-Based
Drugs Market: https://www.omrglobal.com/request-sample/incretin-based-drugs-market
Some major players in the market
include Novo Nordisk A/S, Eli Lilly and Company, and Novartis International AG,
among others. The market players are contributing significantly to the growth
of the market by the adoption of various strategies including mergers & acquisitions,
geographical expansion, partnerships and collaborations, and new product
launches, to stay competitive in the market. For instance, in January 2022,
Novo Nordisk announced the launch of oral semaglutide in India. Oral
semaglutide is the first oral glucagon-like peptide 1 (GLP-1) receptor agonist
used for the treatment of type 2 diabetes.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Drug Type
·
By Route of Administration
·
By Distribution Channel
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- Novo Nordisk A/S, Eli Lilly
and Company, and Novartis International AG, among others.
(Get 15% Discount on Buying this Report)
A
full Report of Incretin-Based Drugs Market is Available @ https://www.omrglobal.com/industry-reports/incretin-based-drugs-market
Global Incretin-Based Drugs Market Report by Segment
By Drug Type
• Glucagon-like
Peptide-1 (GLP-1) Receptor Agonists
• Dipeptidyl
Peptidase-4 (DPP-4) Inhibitors
By Route of Administration
• Oral
• Injectable
By Distribution Channel
• Hospital
Pharmacies
• Retail
Pharmacies
• Others
Global Incretin-Based Drugs Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment